Effect of pamidronate on the action of catecholamines on blood pressure in the marrow cavity of long bones in rats with prednisolone-induced osteoporosis

Pharmacological Reports

Volumn 59, Issue 1, 2007, Pages 58-63

  Kaczmarczyk Sedlak, Ilona ^a   Folwarczna, Joanna ^a   Cegieła, Urszula ^a   Nowińska, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Blood pressure; Catecholamines; Osteoporosis; Pamidronate; Prednisolone; Rat

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN; PAMIDRONIC ACID; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BONE MARROW; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; LONG BONE; MALE; NONHUMAN; OSTEOPOROSIS; RAT;

EID: 34047168818     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Artico M, Bosco S, Cavallotti C, Agostinelli E, Giuliani-Piccari G, Sciorio S, Cocco L et al.: Noradrenergic and cholinergic innervation of the bone marrow. Int J Mol Med, 2002, 10, 77-80.
2. Conrad TJ, Chandler DB, Corless JM, Klintworth GK: In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis. Lab Invest, 1994, 70, 426-434.
3. Ficat RP, Arlet J: Ischemia and Necrosis of Bone. Williams & Wilkins, Baltimore 1980, 196.
4. Frediani U, Bacherini L, Lasagni L, Tanini A, Brandi ML: Catecholamines modulate growth and differentiation of human preosteoclastic cells. Osteoporos Int, 1996, 6, 14-21.
5. Hall JE, Morse CL, Smith MJ Jr, Young DB, Guyton AC: Control of arterial pressure and renal function during glucocorticoid excess in dogs. Hypertension, 1980, 2, 139-148.
6. Hohmann EL, Elde RP, Rysavy JA, Einzig S, Gabhard RL: Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science, 1996, 232, 868-871.
7. Ivarsen P, Jensen LW, Pedersen EB: Circadian blood pressure rhythm and atrial natriuretic peptide in prednisolone-induced blood pressure elevation. Scand J Clin Lab Invest, 1995, 55, 655-662.
8. Jackson SH, Beevers DG, Myers K: Does long-term low-dose corticosteroid therapy cause hypertension? Clin Sci (Lond), 1981, 61, 381S-383S.
9. Jones KB, Mollano AV, Morcuende JA, Cooper RR, Saltzman CL: Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J, 2004, 24, 123-132.
10. Kaczmarczyk-Sedlak I, Cogieła U, Nowińska B, Folwarczna J: The effects of catecholamines on blood pressure in the long marrow cavity in rats with prednisolone-induced osteoporosis. Pharmacol. Rep, 2006, 58, 540-550.
11. Kacmarczyk-Sedlak I, Janiec W: The effects of catecholamines on the intramedullary pressure in the femur in rats with bisphosphonate-induced osteopetrosis. Pharmacol Rep, 2005, 57, 623-634.
12. Nishimura H, Yoshikawa T, Kobayashi N, Anzai T, Nogami K, Handa S, Ogawa S: Effects of methylprednisolone on hemodynamics and beta-adrenergic receptor signaling in rabbits with acute left ventricular failure. Heart Vessels, 1997, 12, 84-91.
13. Pethig K, Heublein B, Wahlers T, Dannenberg O, Oppelt P, Haverich A: Mycophanolate mofetil for secondary prevention of cardiac allograft vasculopathy: infuence on inflammation and progression of intimal hyperplasia. J Heart Lung Transplant, 2004, 23, 61-66.
14. Pongratz G, Zietz B, Gluck T, Scholmerich J, Straub RH: Corticotropin-releasing factor modulates cardiovascular and pupillary autonomic reflexes in man: is there a link to inflammation-induced autonomic nervous hyperreflexia? Ann N Y Acad Sci, 2002, 966, 373-383.
15. Prasad K, Szabo L: Cardiovascular effects of orciprenaline (Alupent) inhalation and prednisolone. Adv Myocardiol, 1980, 1, 437-452.
16. Ribeiro AB, Franco RJ, Kohlmann O Jr, Marson O, Ramos OL: Etiopathogenesis of excess mathylprednisolone arterial hypertension in the rat. Clin Exp Hypertens, 1981, 3, 1219-1237.
17. Sack FU, Raidenbach B, Dollner R, Schledt A, Gebhard MM, Hagl S: Influence of steroids on microvascular perfusion injury of the bowel induced by extracorporeal circulation. Am Thorac Surg, 2001, 72, 1321-1326.
18. Saito T, Takanashi M, Gallagher E, Fuse A, Suzaki S, Inagaki O, Yamada K, Ogawa R: Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med, 1995, 21, 204-210.
19. Sato A, Funder JW, Okubo M, Kubota E, Saruta, T: Glucocorticoid-induced hypertension in the elderly. Relation to serum calcium and family history of essential hypertension. Am J Hypertens, 1995, 8, 823-828.
20. Scherrer D, Lach E, Landry Y, Gies JP: Glucocorticoid modulation of muscarinic and beta-adrenergic receptors in guinea pig lung. Fundam Clin Pharmacol, 1997, 11, 111-116.
21. Tkocz-Kwiatkowska J, Kaczmarczyk-Sedlak I, Folwarczna J: Effects of pamidronate on the development of changes in bone mechanical properties and bone structure caused by the administration of prednisolone in rats. Pol J Pharmacol, 1998, 50, 253-258.
22. Ton FN, Gunawardene SC, Lee H, Neer RM: Effects of low-dose prednisone on bone metabolism. J Bone Miner Res, 2005, 20, 464-470.
23. Whitworth JA: Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int Suppl, 1992, 37, S34-37.
24. Whitworth JA, Gordon D, Andrews J, Scoggins BA: The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens, 1989, 7, 537-549.
25. Ylitalo R, Monkkonen J, Urtti A, Ylitalo P: Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits. J Lab Clin Med, 1996, 127, 200-206.